ALB vs. EMN, AVNT, DD, DOW, SQM, WRK, CF, IP, GFI, and BG
Should you be buying Albemarle stock or one of its competitors? The main competitors of Albemarle include Eastman Chemical (EMN), Avient (AVNT), DuPont de Nemours (DD), DOW (DOW), Sociedad Química y Minera de Chile (SQM), WestRock (WRK), CF Industries (CF), International Paper (IP), Gold Fields (GFI), and Bunge Global (BG). These companies are all part of the "basic materials" sector.
Albemarle (NYSE:ALB) and Eastman Chemical (NYSE:EMN) are both large-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.
92.9% of Albemarle shares are owned by institutional investors. Comparatively, 83.7% of Eastman Chemical shares are owned by institutional investors. 0.4% of Albemarle shares are owned by company insiders. Comparatively, 1.9% of Eastman Chemical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Albemarle has higher revenue and earnings than Eastman Chemical. Albemarle is trading at a lower price-to-earnings ratio than Eastman Chemical, indicating that it is currently the more affordable of the two stocks.
Albemarle received 55 more outperform votes than Eastman Chemical when rated by MarketBeat users. However, 64.59% of users gave Eastman Chemical an outperform vote while only 63.46% of users gave Albemarle an outperform vote.
Albemarle pays an annual dividend of $1.60 per share and has a dividend yield of 1.4%. Eastman Chemical pays an annual dividend of $3.24 per share and has a dividend yield of 3.4%. Albemarle pays out 12.0% of its earnings in the form of a dividend. Eastman Chemical pays out 41.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Albemarle currently has a consensus price target of $175.05, suggesting a potential upside of 49.77%. Eastman Chemical has a consensus price target of $99.31, suggesting a potential upside of 3.93%. Given Albemarle's higher probable upside, analysts plainly believe Albemarle is more favorable than Eastman Chemical.
Albemarle has a net margin of 16.36% compared to Eastman Chemical's net margin of 10.16%. Albemarle's return on equity of 26.62% beat Eastman Chemical's return on equity.
Albemarle has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Comparatively, Eastman Chemical has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500.
In the previous week, Eastman Chemical had 26 more articles in the media than Albemarle. MarketBeat recorded 33 mentions for Eastman Chemical and 7 mentions for Albemarle. Eastman Chemical's average media sentiment score of 0.67 beat Albemarle's score of 0.55 indicating that Eastman Chemical is being referred to more favorably in the news media.
Summary
Albemarle beats Eastman Chemical on 13 of the 20 factors compared between the two stocks.
Get Albemarle News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Albemarle Competitors List
Related Companies and Tools
